National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, Jiangsu, China.
J Nephrol. 2021 Oct;34(5):1747-1756. doi: 10.1007/s40620-020-00948-1. Epub 2021 Mar 2.
Few data are available quantifying the proportion of amyloid deposition in renal biopsy specimens. The aim of the study is to investigate the correlation between the proportion of amyloid deposition in renal biopsy and clinical characteristics of Chinese patients with immunoglobulin light-chain amyloidosis (AL amyloidosis).
259 patients diagnosed with renal AL amyloidosis between 2003 and 2015 were studied retrospectively. We developed a digital, automated quantification method to evaluate amyloid deposits in glomeruli, vessels and interstitium on digital whole-slide images (WSIs). The associations between the proportion of amyloid-positive area in the renal biopsy and clinical manifestations were analyzed.
The proportion (%) of amyloid-positive area in glomeruli, vessels, interstitium and the whole renal tissue were 11.81 ± 11.38, 14.14 ± 14.05, 3.34 ± 5.36 and 4.25 ± 5.77, respectively. The proportion of amyloid deposition in glomeruli, vessels and interstitium was positively correlated with serum creatinine (Scr), estimated glomerular filtration rate (eGFR) and urinary retinol binding protein (RBP). The proportion of glomerular amyloid deposition, age, urinary N-acetyl-b-D-glucosaminidase (NAG) and urinary RBP could independently predict the risk for overall death. The proportion (%) of amyloid-positive area in blood vessels, interstitium and the whole renal tissue, Scr, and urinary RBP were independent risk factors associated with renal survival.
A novel digital analysis algorithm was firstly developed to quantify the proportion of amyloid deposits in renal tissues based on digital WSIs. The degree and localization of amyloid deposits in the kidney evaluated by digital WSIs may have predictive value in assessing risk of outcome of AL amyloidosis.
目前可用的数据很少能定量评估肾活检标本中淀粉样蛋白沉积的比例。本研究旨在探讨中国免疫球蛋白轻链淀粉样变性(AL 淀粉样变性)患者肾活检中淀粉样蛋白沉积比例与临床特征的相关性。
回顾性研究了 2003 年至 2015 年间诊断为肾 AL 淀粉样变性的 259 例患者。我们开发了一种数字自动化定量方法,用于评估数字全切片图像(WSI)上肾小球、血管和间质中的淀粉样沉积物。分析了肾活检中淀粉样阳性面积比例与临床表现之间的相关性。
肾小球、血管、间质和整个肾组织中淀粉样阳性面积的比例分别为 11.81±11.38%、14.14±14.05%、3.34±5.36%和 4.25±5.77%。肾小球、血管和间质中的淀粉样沉积比例与血清肌酐(Scr)、估计肾小球滤过率(eGFR)和尿视黄醇结合蛋白(RBP)呈正相关。肾小球淀粉样沉积比例、年龄、尿 N-乙酰-β-D-氨基葡萄糖苷酶(NAG)和尿 RBP 可独立预测总死亡风险。血管、间质和整个肾组织中淀粉样阳性面积的比例、Scr 和尿 RBP 是与肾生存相关的独立危险因素。
本研究首次开发了一种基于数字 WSI 的定量评估肾脏组织中淀粉样蛋白沉积比例的新数字分析算法。数字 WSI 评估的肾脏中淀粉样蛋白沉积的程度和定位可能对评估 AL 淀粉样变性患者的预后风险具有预测价值。